Mumbai, India
Inventys Research Company, founded in 2005 and headquartered in India, positions itself as a leader in delivering Exclusive Synthesis and CDMO services for the Agro Pharma and Specialty Chemicals sectors. With its slogan, "Sustainable & safe manufacturer providing Exclusive Synthesis & CDMO Services," the company distinguishes itself through robust sustainable practices, evidenced by sourcing over 51% of its energy from renewable resources since 2012.
Acclaimed for its commitment to sustainability, Inventys earned the FICCI Best Green Process Award in 2022. It is recognized for leading in Flow Chemistry with significant commercial-scale achievements. Compliance with WHO GMP, ISO 9001, ISO 14001, and ISO 45000 standards underscores its quality and reliability.
This strategic positioning has bolstered Inventys' reputation in demanding markets across the USA, Western Europe, and Japan, where it garners 75% of its revenue. As of 2023, Inventys was named one of the “250 fastest growing companies in Asia Pacific” by the Financial Times.
Additionally, Inventys is poised for expansion with plans to grow its reactor capacity from 150+ in 2024 to 340+ by 2030. With no existing debt, the company received an INR2.25B venture investment on April 21, 2021, led by Pantomath Capital Advisors Private Limited and Plutus Wealth Management. This financial backing supports Inventys' ambitions to scale further.
